Jennifer Berres Sells 8,020 Shares of HCA Healthcare (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) SVP Jennifer Berres sold 8,020 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. The trade was a 40.07% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $539.91 on Friday. The stock has a market cap of $120.73 billion, a P/E ratio of 19.02, a price-to-earnings-growth ratio of 1.64 and a beta of 1.36. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $552.90. The firm’s fifty day moving average price is $482.80 and its 200-day moving average price is $448.23.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to analyst estimates of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is currently 10.99%.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s share performance is strong on a year‑over‑year basis (shares up ~75% YoY), reinforcing momentum and investor confidence in the company’s results and outlook. Read More.
• Positive Sentiment: Zacks and other analysts highlight earnings growth and price strength; Zacks added HCA to focus coverage and raised FY‑2026 EPS estimates, supporting forward earnings momentum and valuation. Read More.
• Positive Sentiment: HCA raised its quarterly dividend (new quarterly payout announced), which narrows yield risk and is a modest positive for income‑oriented investors. Read More.
• Positive Sentiment: Large institutional flows and stake increases (e.g., Norges Bank, Pacer, Viking Global) point to strong institutional demand and provide technical/supportive buying pressure for the stock. Read More.
• Neutral Sentiment: HCA completed a 43‑hospital EHR rollout and is tracking success metrics — operational execution that can improve efficiency and integration over time but has a gradual, not immediate, earnings impact. Read More.
• Neutral Sentiment: Local expansion moves — HCA Houston Healthcare Tomball acquired Supreme Care ER and StoneSprings plans a freestanding ER conversion — small, market‑level capacity adds that could modestly lift volumes in those geographies. Read More.
• Neutral Sentiment: HCA sold ASC real estate — a financing/portfolio move that could free capital or change lease terms; impact depends on transaction use of proceeds. Read More.
• Negative Sentiment: Insider selling: two senior VPs disclosed multi‑million dollar sales (Christopher Wyatt sold ~$2.0M; Jennifer Berres sold ~$4.13M). Significant insider sales can create short‑term selling pressure or raise governance/portfolio‑rebalancing questions. Read More. Read More.
• Negative Sentiment: Zacks/other outlets flagged a downward revision to HCA’s Q1 EPS forecast, which can pressure near‑term expectations even as FY estimates were raised. Read More.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. TD Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. KeyCorp set a $503.00 price target on HCA Healthcare in a research note on Wednesday, January 28th. Argus raised their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the stock a “buy” rating in a report on Friday, February 6th. Barclays raised their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Finally, Robert W. Baird upped their price target on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $523.27.

Institutional Trading of HCA Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of HCA. Brighton Jones LLC purchased a new stake in HCA Healthcare in the fourth quarter worth about $1,021,000. NewEdge Advisors LLC increased its position in HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after buying an additional 409 shares in the last quarter. Sivia Capital Partners LLC boosted its holdings in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares in the last quarter. Concurrent Investment Advisors LLC increased its holdings in shares of HCA Healthcare by 4.3% during the second quarter. Concurrent Investment Advisors LLC now owns 2,235 shares of the company’s stock valued at $856,000 after acquiring an additional 93 shares in the last quarter. Finally, CWM LLC grew its position in HCA Healthcare by 5.4% during the 2nd quarter. CWM LLC now owns 13,062 shares of the company’s stock valued at $5,004,000 after purchasing an additional 667 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.